These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16179840)
1. [Expression of Cdx2 protein in colorectal cancer]. Pack JH; Kim TD; Oh HA; Lee EJ; Kim JW; Jang BI; Kim TN; Jung MK; Bae YK Korean J Gastroenterol; 2005 Sep; 46(3):204-10. PubMed ID: 16179840 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of CDX2 in colorectal cancers. Choi BJ; Kim CJ; Cho YG; Song JH; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS APMIS; 2006 Jan; 114(1):50-4. PubMed ID: 16499661 [TBL] [Abstract][Full Text] [Related]
3. Reduced CDX2 expression predicts poor overall survival in patients with colorectal cancer. Hong KD; Lee D; Lee Y; Lee SI; Moon HY Am Surg; 2013 Apr; 79(4):353-60. PubMed ID: 23574843 [TBL] [Abstract][Full Text] [Related]
4. Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma. Bakaris S; Cetinkaya A; Ezberci F; Ekerbicer H Histol Histopathol; 2008 Sep; 23(9):1043-7. PubMed ID: 18581275 [TBL] [Abstract][Full Text] [Related]
5. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523 [TBL] [Abstract][Full Text] [Related]
6. Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas. Sen A; Mitra S; Das RN; Dasgupta S; Saha K; Chatterjee U; Mukherjee K; Datta C; Chattopadhyay BK Indian J Pathol Microbiol; 2015; 58(2):158-62. PubMed ID: 25885126 [TBL] [Abstract][Full Text] [Related]
7. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype. Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685 [TBL] [Abstract][Full Text] [Related]
8. Relationships between the expressions of CDX1 and CDX2 mRNA and clinicopathologic features in colorectal cancers. Kim GH; Lee DH; Kim HW; Cheong JY; Seo SB; Heo J; Kang DH; Song GA; Cho M; Yang US; Park DY; Yoo MA Korean J Intern Med; 2005 Dec; 20(4):317-24. PubMed ID: 16491830 [TBL] [Abstract][Full Text] [Related]
9. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397 [TBL] [Abstract][Full Text] [Related]
11. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens. Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351 [TBL] [Abstract][Full Text] [Related]
12. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Fan Z; Li J; Dong B; Huang X Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916 [TBL] [Abstract][Full Text] [Related]
13. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. Bae JM; Lee TH; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765 [TBL] [Abstract][Full Text] [Related]
14. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2. Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108 [TBL] [Abstract][Full Text] [Related]
15. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
16. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879 [TBL] [Abstract][Full Text] [Related]
17. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Witek ME; Nielsen K; Walters R; Hyslop T; Palazzo J; Schulz S; Waldman SA Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8549-56. PubMed ID: 16361536 [TBL] [Abstract][Full Text] [Related]
18. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis. Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409 [TBL] [Abstract][Full Text] [Related]
19. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980 [TBL] [Abstract][Full Text] [Related]
20. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors]. Gaggero G; Sola S; Mora M; Fulcheri E Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]